Web7 Dec 2024 · Cheema: Unum Therapeutics Inc.: Employment. Topics: adaptability , antibodies , daratumumab , t-cell receptor , t-lymphocytes , multiple myeloma , chimeric … Web9 Jun 2024 · Seth Ettenberg, PhD, is the current President and CEO of BlueRock Therapeutics. Seth served as Chief Scientific Officer at BlueRock from 2024 – 2024. Prior to joining BlueRock, Seth was a founding member of the Unum Therapeutics team, where he served as Chief Scientific Officer.
Cellular Immunotherapy & Unum Therapeutics: Out Of Many, …
WebSeth A. Ettenberg's 50 research works with 1,827 citations and 4,280 reads, including: BOXR1030, an anti-GPC3 CAR with exogenous GOT2 expression, shows enhanced T cell metabolism and improved anti ... WebSeth Ettenberg is a Strategic Advisor at Manifold Bio, and they have also served as the Chief Scientific Officer at Unum Therapeutics, Oncology Biotherapeutics Head at the Cambridge site of Novartis, and Lab Head and Project Leader at CuraGen Corp. Ettenberg has been working in the field of oncology biotherapeutics for over 20 years. companies in nottingham
Seth A. Ettenberg
WebFind out what research areas Seth Ettenberg is interested in, their current and past organizations and any investments they've made here! ... Digital Therapeutics. Cell … Web9 Nov 2024 · For almost a decade, Ettenberg ran a research team at NIBR, and became head of oncology biotherapeutics in Cambridge. In 2014, Ettenberg was a founding member of the Unum Therapeutics team, where he served as Chief Scientific Officer. In this role, he built and led teams that brought several novel cellular therapies from invention to clinical ... Web8 Dec 2024 · Author links open overlay panel Taylor Hickman BS * 1 Adrianna Graziano * 1 Katie O'Callaghan PhD * 1 Ryan Boomer BA * 1 Eugene Choi MS * 1 Allison Nelson BS * 1 Greg Motz PhD * 1 Jessica Sachs MD * 1 Birgit Schultes PhD * 1 Seth Ettenberg PhD 2 Tooba Cheema PhD * 1 eat n park south hills village mall